biospecimen__admin__batch_number	365.54.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	A1F9A17B-BC21-4D29-9EA5-A4E7680937FB
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-ED-A7XO-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-ED-A7XO-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-ED-A7XO-01A
biospecimen__bio__biospecimen_barcode_bottom	0160339645
biospecimen__bio__day_of_creation	22
biospecimen__bio__day_of_shipment	18
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	10
biospecimen__bio__month_of_shipment	12
biospecimen__bio__pathology_report_file_name	TCGA-ED-A7XO.3FC3BB34-8E4A-4422-BFEF-58B15947F032.pdf
biospecimen__bio__plate_column	11
biospecimen__bio__plate_id	A352
biospecimen__bio__plate_row	C
biospecimen__bio__portion_sequence	1
biospecimen__bio__quantity	2.21
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	13.00
biospecimen__bio__year_of_creation	2013
biospecimen__bio__year_of_shipment	2013
biospecimen__shared__bcr_patient_barcode	TCGA-ED-A7XO
biospecimen__shared__patient_id	A7XO
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	92471461-1B52-4A4A-A1B3-1DEA080E652A
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.8
clinical__chol_lihc_shared__albumin_result_specified_value	4.2
clinical__chol_lihc_shared__albumin_result_upper_limit	5.1
clinical__chol_lihc_shared__bilirubin_lower_limit	0.1
clinical__chol_lihc_shared__bilirubin_upper_limit	0.6
clinical__chol_lihc_shared__creatinine_lower_level	4.1
clinical__chol_lihc_shared__creatinine_upper_limit	5.9
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	4.9
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_value	4
clinical__chol_lihc_shared__hist_hepato_carc_fact	No History of Primary Risk Factors
clinical__chol_lihc_shared__specimen_collection_method_name	Lobectomy
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.3
clinical__chol_lihc_shared__vascular_tumor_cell_type	Micro
clinical__clin_shared__age_at_initial_pathologic_diagnosis	29
clinical__clin_shared__bcr_followup_barcode	TCGA-ED-A7XO-F65727
clinical__clin_shared__bcr_followup_uuid	7FB7AF17-2C67-4456-89C5-83A72AEA5E6A
clinical__clin_shared__day_of_form_completion	8
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__month_of_form_completion	12
clinical__clin_shared__person_neoplasm_cancer_status	WITH TUMOR
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	NO
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	YES
clinical__clin_shared__tissue_retrospective_collection_indicator	NO
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__viral_hepatitis_serology	Hepatitis  C Antibody
clinical__clin_shared__year_of_form_completion	2014
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2013
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	Mild
clinical__nte__additional_radiation_therapy	NO
clinical__nte__days_to_new_tumor_event_after_initial_treatment	262
clinical__nte__new_neoplasm_event_occurrence_anatomic_site	Liver
clinical__nte__new_tumor_event_after_initial_treatment	YES
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G2
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T3a
clinical__shared_stage__system_version	7th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	22e11be6-f4ce-47a6-8c50-5eb957834906
gdc__aliquots__concentration	0.17
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-ED-A7XO-01A-11R-A352-07
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	771304df-78cd-4527-911c-2d16189f62ca,5d8c67c3-21ad-4930-b225-a891440833a3,dda59210-8ca0-4b8b-baae-7e6729d00e5f
gdc__analysis__workflow_link	https://github.com/NCI-GDC/htseq-cwl
gdc__analysis__workflow_type	HTSeq - Counts,HTSeq - FPKM-UQ,HTSeq - FPKM
gdc__analysis__workflow_version	v1
gdc__analytes__a260_a280_ratio	1.81
gdc__analytes__analyte_id	4cc21af0-8837-4473-a98f-ab32ffdbe5c9
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	20bb3855-66e2-46d4-b189-006b4b254c2e
gdc__center__center_id	ee7a85b3-8177-5d60-a10c-51180eb9009c
gdc__center__center_type	CGCC
gdc__center__code	07
gdc__center__name	University of North Carolina
gdc__center__namespace	unc.edu
gdc__center__short_name	UNC
gdc__created_datetime	2016-05-26T21:21:05.719494-05:00,2016-05-26T21:21:05.895914-05:00,2016-05-26T21:21:06.221237-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	Gene Expression Quantification
gdc__demographic__demographic_id	e8871f2b-e212-5e8e-89d6-cd6ea7c25e3e
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	male
gdc__demographic__race	asian
gdc__demographic__year_of_birth	1984
gdc__diagnoses__age_at_diagnosis	10828
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-10828.0
gdc__diagnoses__days_to_last_follow_up	427.0
gdc__diagnoses__diagnosis_id	b488f949-942a-5cc6-a178-32cb645791b0
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage iiia
gdc__diagnoses__vital_status	alive
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	RNA-Seq
gdc__exposures__bmi	20.897959183673468
gdc__exposures__exposure_id	90013c52-8239-5819-847f-6127a755ae59
gdc__exposures__height	175.0
gdc__exposures__weight	64.0
gdc__file_id	22b38dcf-3a98-4f7d-9306-67c25331c6f4,493fb01c-c831-4c61-9ebb-8b6568b45d1e,ac558fa7-d896-498d-9948-21af4b134de0
gdc__file_name	697d372a-b7b7-46fa-8f96-9a11997e47b8.htseq.counts.gz,697d372a-b7b7-46fa-8f96-9a11997e47b8.FPKM-UQ.txt.gz,697d372a-b7b7-46fa-8f96-9a11997e47b8.FPKM.txt.gz
gdc__file_size	245102,492560,490969
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	RNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	36b17a7ff1f60c48831d15187cfd752d,57556009691e1305418165482f6167ee,2472e6b45b5898b5d6d3991a6a6ea54a
gdc__portions__is_ffpe	false
gdc__portions__portion_id	0cc65b2c-23a7-4444-868f-0850cfefc81f
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	77
gdc__samples__initial_weight	1430.0
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	3FC3BB34-8E4A-4422-BFEF-58B15947F032
gdc__samples__sample_id	8ae44ec9-741c-484b-a784-a0cb2f02aaa0
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	4.0
gdc__slides__percent_monocyte_infiltration	1.0
gdc__slides__percent_necrosis	10.0
gdc__slides__percent_neutrophil_infiltration	1.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	60.0
gdc__slides__percent_tumor_cells	30.0
gdc__slides__percent_tumor_nuclei	75.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	33a55f27-b4ff-4ccc-9d2e-fc6be4cae19a
gdc__submitter_id	697d372a-b7b7-46fa-8f96-9a11997e47b8_count,697d372a-b7b7-46fa-8f96-9a11997e47b8_uqfpkm,697d372a-b7b7-46fa-8f96-9a11997e47b8_fpkm
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	ED
gdc__tissue_source_site__name	Asterand
gdc__tissue_source_site__tissue_source_site_id	8d5c4bc3-5ad6-5c07-8738-a6632e4d59d4
gdc__treatments__treatment_id	08587143-8cf0-55be-b2a8-9bd33b4e4fdc
gdc__type	gene_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T08:05:44.536+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/gene_expression_quantification/22e11be6-f4ce-47a6-8c50-5eb957834906-geq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/gene_expression_quantification/22e11be6-f4ce-47a6-8c50-5eb957834906-geq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	5051488
manually_curated__local_md5	a435d5cfe24321e1a36c6022c2b47837
manually_curated__opengdc_download_date	2018-10-15T16:29:49.000846+02:00
manually_curated__opengdc_file_md5	d259ea2bfee090f0f8eec569d5b5b986
manually_curated__opengdc_file_size	1648553
manually_curated__opengdc_id	22e11be6-f4ce-47a6-8c50-5eb957834906-geq
manually_curated__origin_file_size	5051488
manually_curated__origin_last_modified_date	Mon Oct 15 16:40:00 CEST 2018
manually_curated__origin_md5	a435d5cfe24321e1a36c6022c2b47837
manually_curated__tissue_status	tumoral
num	60483
